アンジェスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 64 | 65 | 60 | 61 | -3 | -4.7% | 8,041,800 |
| 2025/04/03 | 62 | 66 | 62 | 64 | +1 | +1.6% | 5,363,000 |
| 2025/04/02 | 65 | 67 | 63 | 63 | -3 | -4.5% | 3,683,800 |
| 2025/04/01 | 67 | 70 | 65 | 66 | -1 | -1.5% | 5,574,900 |
| 2025/03/31 | 68 | 68 | 64 | 67 | -3 | -4.3% | 10,974,000 |
| 2025/03/28 | 73 | 74 | 68 | 70 | +1 | +1.4% | 13,289,000 |
| 2025/03/27 | 66 | 69 | 65 | 69 | +5 | +7.8% | 5,226,100 |
| 2025/03/26 | 61 | 65 | 61 | 64 | +3 | +4.9% | 6,392,400 |
| 2025/03/25 | 64 | 64 | 60 | 61 | -3 | -4.7% | 10,646,900 |
| 2025/03/24 | 65 | 66 | 64 | 64 | -1 | -1.5% | 4,249,800 |
| 2025/03/21 | 65 | 69 | 64 | 65 | +1 | +1.6% | 5,322,700 |
| 2025/03/19 | 63 | 67 | 63 | 64 | ±0 | ±0% | 9,035,500 |
| 2025/03/18 | 66 | 67 | 63 | 64 | -2 | -3% | 4,570,400 |
| 2025/03/17 | 68 | 68 | 64 | 66 | ±0 | ±0% | 5,454,700 |
| 2025/03/14 | 64 | 69 | 63 | 66 | +3 | +4.8% | 8,944,600 |
| 2025/03/13 | 61 | 65 | 61 | 63 | +3 | +5% | 3,239,600 |
| 2025/03/12 | 66 | 67 | 60 | 60 | -6 | -9.1% | 7,763,200 |
| 2025/03/11 | 64 | 66 | 62 | 66 | +1 | +1.5% | 4,945,800 |
| 2025/03/10 | 65 | 67 | 64 | 65 | ±0 | ±0% | 4,453,500 |
| 2025/03/07 | 64 | 66 | 62 | 65 | ±0 | ±0% | 7,288,000 |
| 2025/03/06 | 66 | 68 | 64 | 65 | ±0 | ±0% | 4,832,900 |
| 2025/03/05 | 67 | 69 | 65 | 65 | -2 | -3% | 4,918,100 |
| 2025/03/04 | 68 | 70 | 65 | 67 | -2 | -2.9% | 11,298,600 |
| 2025/03/03 | 73 | 77 | 69 | 69 | -2 | -2.8% | 16,612,200 |
| 2025/02/28 | 77 | 78 | 71 | 71 | -6 | -7.8% | 14,486,200 |
| 2025/02/27 | 78 | 80 | 73 | 77 | +2 | +2.7% | 15,404,000 |
| 2025/02/26 | 75 | 78 | 72 | 75 | -1 | -1.3% | 13,100,800 |
| 2025/02/25 | 76 | 80 | 69 | 76 | +7 | +10.1% | 31,320,700 |
| 2025/02/21 | 62 | 69 | 61 | 69 | +7 | +11.3% | 12,497,900 |
| 2025/02/20 | 61 | 63 | 59 | 62 | +2 | +3.3% | 3,867,500 |
| 2025/02/19 | 63 | 64 | 60 | 60 | -2 | -3.2% | 5,967,300 |
| 2025/02/18 | 59 | 65 | 58 | 62 | +5 | +8.8% | 10,862,300 |
| 2025/02/17 | 55 | 59 | 54 | 57 | +2 | +3.6% | 6,875,900 |
| 2025/02/14 | 58 | 59 | 54 | 55 | -4 | -6.8% | 8,625,500 |
| 2025/02/13 | 53 | 59 | 52 | 59 | +6 | +11.3% | 9,600,700 |
| 2025/02/12 | 54 | 54 | 52 | 53 | ±0 | ±0% | 694,700 |
| 2025/02/10 | 52 | 54 | 51 | 53 | -1 | -1.9% | 8,178,100 |
| 2025/02/07 | 51 | 54 | 50 | 54 | +4 | +8% | 6,419,400 |
| 2025/02/06 | 51 | 52 | 49 | 50 | +1 | +2% | 9,660,700 |
| 2025/02/05 | 50 | 52 | 49 | 49 | ±0 | ±0% | 8,288,300 |
| 2025/02/04 | 48 | 51 | 48 | 49 | +2 | +4.3% | 12,730,800 |
| 2025/02/03 | 47 | 49 | 46 | 47 | ±0 | ±0% | 5,463,700 |
| 2025/01/31 | 48 | 48 | 46 | 47 | ±0 | ±0% | 3,242,700 |
| 2025/01/30 | 47 | 48 | 46 | 47 | ±0 | ±0% | 2,706,800 |
| 2025/01/29 | 48 | 50 | 46 | 47 | -1 | -2.1% | 6,423,700 |
| 2025/01/28 | 47 | 48 | 46 | 48 | +1 | +2.1% | 2,856,500 |
| 2025/01/27 | 49 | 49 | 46 | 47 | -1 | -2.1% | 7,214,400 |
| 2025/01/24 | 48 | 49 | 46 | 48 | ±0 | ±0% | 6,923,800 |
| 2025/01/23 | 49 | 50 | 48 | 48 | -1 | -2% | 3,361,800 |
| 2025/01/22 | 49 | 50 | 48 | 49 | ±0 | ±0% | 3,153,000 |
1～
50
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| アンジェス | 6,100円 | +110.0% | - | 0.00% | - | 9.73倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ヘリオス | 22,400円 | +150.0% | - | 0.00% | - | 11.00倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 扶桑薬 | 225,000円 | +8.3% | +98.1% | 3.64% | 7.39倍 | 0.51倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 28,700円 | - | - | 0.00% | - | 2.65倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| ＣＡＮＢＡＳ | 89,300円 | - | - | 0.00% | - | 5.71倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム
